Corbus Pharma (CRBP) Misses Q4 EPS by 78c
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Join SI Premium – FREE
Corbus Pharma (NASDAQ: CRBP) reported Q4 EPS of ($0.78).
For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- CopperTech Metals files for IPO on NYSE under ticker CUX
- Crescent Biopharma (CBIO) Reiterated at Buy by Stifel on CR-003/SKB105 Potential
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
